The tape has that hollow, echo-chamber feel you only get before a major regime test—where every tick feels like a market trying to inhale without knowing whether the next exhale will be relief or ...

Novo Nordisk (NVO), the Danish pharmaceutical giant behind blockbuster obesity and diabetes treatments Ozempic and Wegovy, finds itself at a technical breaking point that could define its trajectory ...